• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌在当前吸烟者中发病时间提前6年:对日本泌尿外科学会癌症登记委员会收集的膀胱癌登记数据的分析。

Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association.

作者信息

Hinotsu Shiro, Akaza Hideyuki, Miki Tsuneharu, Fujimoto Hiroyuki, Shinohara Nobuo, Kikuchi Eiji, Mizutani Yoichi, Koga Hirofumi, Okajima Eijiro, Okuyama Akihiko

机构信息

Urology and Andrology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.

出版信息

Int J Urol. 2009 Jan;16(1):64-9. doi: 10.1111/j.1442-2042.2008.02194.x. Epub 2008 Nov 27.

DOI:10.1111/j.1442-2042.2008.02194.x
PMID:19054170
Abstract

OBJECTIVES

It is generally recognized that cigarette smoking is the most important risk factor for bladder cancer. The present study was undertaken to examine the relationships between smoking history of bladder cancer patients and the age of onset of bladder cancer and tumor characteristics.

METHODS

The present study examined the data for 5959 cases (4728 males and 1231 females) collected in the bladder cancer database of the Japanese Urological Association from 1999 to 2001. Patients were divided by smoking history into three categories as current non-smokers, current smokers and unknown smoking history. Relationship between smoking history and the age at diagnosis of bladder cancer, gender, T stage, grade, tumor size, tumor number and initial symptoms was analyzed.

RESULTS

In both males and females the onset of bladder cancer is about 6 years (6.1 years in males and 5.9 years in females) earlier for current smokers than for current non-smokers. At the time of diagnosis, tumor stage was significantly higher in the current smokers group. The current smokers group tended to have larger tumor size.

CONCLUSIONS

The finding of 6-year-earlier onset of bladder cancer among current smokers is of great importance to both health care and medical economics. It is essential to make people better informed concerning the need to quit smoking.

摘要

目的

人们普遍认为吸烟是膀胱癌最重要的危险因素。本研究旨在探讨膀胱癌患者的吸烟史与膀胱癌发病年龄及肿瘤特征之间的关系。

方法

本研究调查了1999年至2001年日本泌尿外科学会膀胱癌数据库中收集的5959例病例(4728例男性和1231例女性)的数据。患者按吸烟史分为三类:当前不吸烟者、当前吸烟者和吸烟史不明者。分析了吸烟史与膀胱癌诊断年龄、性别、T分期、分级、肿瘤大小、肿瘤数量及初始症状之间的关系。

结果

无论是男性还是女性,当前吸烟者的膀胱癌发病时间比当前不吸烟者早约6年(男性为6.1年,女性为5.9年)。在诊断时,当前吸烟者组的肿瘤分期明显更高。当前吸烟者组的肿瘤大小往往更大。

结论

当前吸烟者膀胱癌发病早6年这一发现对医疗保健和医疗经济学都非常重要。让人们更好地了解戒烟的必要性至关重要。

相似文献

1
Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association.膀胱癌在当前吸烟者中发病时间提前6年:对日本泌尿外科学会癌症登记委员会收集的膀胱癌登记数据的分析。
Int J Urol. 2009 Jan;16(1):64-9. doi: 10.1111/j.1442-2042.2008.02194.x. Epub 2008 Nov 27.
2
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.根据日本登记膀胱癌患者的数据得出的Ta、T1期非肌层浸润性膀胱癌肿瘤复发的临床结果:日本泌尿外科学会1999 - 2001年报告
Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.
3
Trends in the incidence of bladder cancer in Nova Scotia: a twenty-year perspective.新斯科舍省膀胱癌发病率趋势:二十年视角
Can J Urol. 2003 Jun;10(3):1880-4.
4
Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.台湾女性非肌层浸润性膀胱癌的特征:与上尿路尿路上皮癌和终末期肾病的关联
Urology. 2008 Jun;71(6):1155-60. doi: 10.1016/j.urology.2007.11.140. Epub 2008 Apr 18.
5
Impact of smoking on mortality in 80-year-old Japanese from the general population.吸烟对日本80岁普通人群死亡率的影响。
Gerontology. 2008;54(4):210-6. doi: 10.1159/000138336. Epub 2008 Jun 17.
6
Urological implications of concurrent bladder and lung cancer.膀胱癌与肺癌并存的泌尿系统影响
Isr Med Assoc J. 2007 Oct;9(10):732-5.
7
Barbiturates, smoking, and bladder cancer risk.巴比妥类药物、吸烟与膀胱癌风险。
Cancer Epidemiol Biomarkers Prev. 1998 Nov;7(11):1049-50.
8
Clinical-pathological differences and smoking habit depending on gender in a cohort of patients with transitional cell carcinoma of the bladder: retrospective study.膀胱癌移行细胞癌患者队列中临床病理差异及吸烟习惯与性别的关系:回顾性研究
Arch Esp Urol. 2011 Jun;64(5):427-33.
9
Cigarette smoking and chromosome 9 alterations in bladder cancer.吸烟与膀胱癌中的9号染色体改变
Cancer Epidemiol Biomarkers Prev. 1997 May;6(5):321-6.
10
[The report of clinical statistical studies on registered bladder cancer patients in Japan 1982-1987. Japanese Urological Association, Committee on General Rule for Studies on Bladder Cancer].[1982 - 1987年日本登记膀胱癌患者的临床统计研究报告。日本泌尿外科学会,膀胱癌研究总则委员会]
Nihon Hinyokika Gakkai Zasshi. 1991 Dec;82(12):1905-15.

引用本文的文献

1
Aggressive Bladder Urothelial Carcinoma in an HIV-Positive Male With Neurogenic Bladder Dysfunction due to Spina Bifida: An Autopsy Case.一名因脊柱裂导致神经源性膀胱功能障碍的HIV阳性男性的侵袭性膀胱尿路上皮癌:一例尸检病例
IJU Case Rep. 2025 Mar 25;8(3):261-265. doi: 10.1002/iju5.70020. eCollection 2025 May.
2
Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder Cancer.沉默线粒体门卫蛋白 VDAC1 作为膀胱癌潜在治疗方法。
Cells. 2024 Apr 4;13(7):627. doi: 10.3390/cells13070627.
3
Risk Factors for Bladder Cancer: Results of a Survey of Hospital Patients.
膀胱癌的风险因素:一项医院患者调查的结果
J Cancer Allied Spec. 2023 Jan 13;9(1):485. doi: 10.37029/jcas.v9i1.485. eCollection 2023.
4
Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription.长链非编码 RNA SNHG1 通过上调 EZH2 和抑制 KLF2 转录促进膀胱癌进展。
Clinics (Sao Paulo). 2022 Sep 7;77:100081. doi: 10.1016/j.clinsp.2022.100081. eCollection 2022.
5
A glance at the emerging diagnostic biomarkers in the most prevalent genitourinary cancers.一瞥最常见的泌尿生殖系统癌症中新兴的诊断生物标志物。
Saudi J Biol Sci. 2022 Apr;29(4):2072-2084. doi: 10.1016/j.sjbs.2022.01.017. Epub 2022 Jan 15.
6
New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors.晚期膀胱癌靶向治疗的新方向与挑战:FGFR抑制剂的作用
Cancers (Basel). 2022 Mar 10;14(6):1416. doi: 10.3390/cancers14061416.
7
Bladder cancer trends in Latvia during 1990-2017: incidence, mortality, and survival rates.1990 - 2017年拉脱维亚膀胱癌发病趋势:发病率、死亡率和生存率
Cent European J Urol. 2021;74(1):14-23. doi: 10.5173/ceju.2021.0266.R2. Epub 2021 Feb 18.
8
Epidemiology of Bladder Cancer.膀胱癌流行病学
Med Sci (Basel). 2020 Mar 13;8(1):15. doi: 10.3390/medsci8010015.
9
Tolerability and Efficacy of Neoadjuvant Chemotherapy with a Tri-Weekly Interval Methotrexate, Doxorubicin, Vinblastine, and Cisplatin Regimen for Patients with Locally Advanced Bladder Cancer.每三周一次甲氨蝶呤、阿霉素、长春碱和顺铂方案新辅助化疗对局部晚期膀胱癌患者的耐受性和疗效
Case Rep Oncol. 2018 Jul 5;11(2):450-460. doi: 10.1159/000490458. eCollection 2018 May-Aug.
10
Bladder cancer in HIV-infected adults: an emerging concern?感染HIV的成年人中的膀胱癌:一个新出现的问题?
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19647. doi: 10.7448/IAS.17.4.19647. eCollection 2014.